Home LiteratureArticle Details
PMID: 9219943 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Neurotoxic consequences of central long-term administration of interleukin-2 in rats.

Neuroscience ·Vol. 79 ·No. 3 ·1997-08-00 ·Pages 799-818

Hanisch UK, Neuhaus J, Rowe W, Van Rossum D, Möller T, Kettenmann H, Quirion R

Abstract

Interleukin-2 is an immunoregulatory cytokine with several recently established CNS activities. Central effects of interleukin-2 include growth promotion for neuronal and glial cells as well as modulatory influences on neurotransmission and hormone release. However, little is known about the consequences in the CNS of chronically elevated levels of interleukin-2. Alterations in the interleukin-2/interleukin-2 receptor system are not only associated with CNS trauma, inflammation and certain neuropathologies; elevated interleukin-2 concentrations are especially induced during the therapeutic use of interleukin-2 in cancer treatments. In the present study, intracerebroventricular (i.c.v.) interleukin-2 infusions (5 15 U/h) were performed in Sprague Dawley rats for up to 14 days. Interleukin-2-treated animals showed significantly increased plasma levels of corticosterone indicating an hyperfunctioning of the hypothalamic-pituitary-adrenocortical axis that lasted over the 14 day infusion period. Moreover, the performance of interleukin-2-treated animals in the Morris swim maze task was transiently impaired. Quantitative receptor autoradiographic analyses revealed changes in the binding levels of cholinergic M1 and M2 as well as dopaminergic D1 and D2 receptors in selected brain areas in which interleukin-2 was shown to modulate neurotransmission and which are enriched with interleukin-2 receptor expression. Decreased receptor binding levels were observed in the frontoparietal cortex (M2, D1, D2), hippocampal CA1 region (M1, M2) and the nucleus accumbens (D2). Histological and immunohistochemical examination of the brains of interleukin-2-treated animals revealed multiple alterations. Interleukin-2 treatment resulted in an intracranial accumulation of non-neural, MHC class II-positive cells as well as T and B lymphocytes within the infused brain hemisphere. Cellular infiltrates were associated with angiogenesis and the deposition of extracellular matrix material, such as fibronectin. Adjacent brain regions that were partly invaded and dislodged by the cellular masses were characterized by reactive astrogliosis, microglial activation, endothelial upregulation of adhesion molecules, myelin damage and neuronal loss. Together the data suggest that persistently elevated central levels of interleukin-2 can interfere with several CNS functions and may lead to nervous tissue injury. These findings could be relevant to CNS pathologies characterized by abnormal interleukin-2 production and to central responses to interleukin-2 treatments.

MeSH Terms
Animals Autoradiography Brain/drug effects,ultrastructure Injections, Intraventricular Interleukin-2/toxicity Male Microscopy, Confocal Rats Rats, Sprague-Dawley Time Factors
Chemicals
Interleukin-2
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Hanisch U K
Max Delbruck Center for Molecular Medicine, Cellular Neurosciences, Berlin-Buch, Germany.
Neuhaus J
Rowe W
Van Rossum D
Möller T
Kettenmann H
Quirion R
Article Info
Journal
Neuroscience
Abbr.
Neuroscience
ISSN
0306-4522
Published
1997-08-00
Pages
799-818
Language
English
Region
United States
NLM ID
7605074
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]